• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Prevalence and correlates of postdiagnosis initiation of complementary and alternative medicine among patients at a comprehensive cancer center.综合癌症中心患者诊断后开始采用补充和替代医学的流行情况及其相关因素。
J Oncol Pract. 2013 Jan;9(1):34-41. doi: 10.1200/JOP.2012.000634.
2
Complementary and Alternative Medicine Use at a Comprehensive Cancer Center.一家综合癌症中心的补充和替代医学应用
Integr Cancer Ther. 2017 Mar;16(1):104-109. doi: 10.1177/1534735416643384. Epub 2016 May 4.
3
Complementary and alternative medicine use by pediatric oncology patients before, during, and after treatment.儿科肿瘤患者在治疗前后使用补充和替代医学。
BMC Complement Med Ther. 2021 Mar 18;21(1):96. doi: 10.1186/s12906-021-03271-9.
4
Complementary and Alternative Medicine Use in Individuals Presenting for Care at a Comprehensive Cancer Center.在一家综合癌症中心就诊的患者中补充和替代医学的使用情况。
Integr Cancer Ther. 2017 Mar;16(1):96-103. doi: 10.1177/1534735416660384. Epub 2016 Jul 21.
5
Complementary and Alternative Medicine Use in Women With Gynecologic Malignancy Presenting for Care at a Comprehensive Cancer Center.在一家综合癌症中心就诊的妇科恶性肿瘤女性患者中补充和替代医学的使用情况
Int J Gynecol Cancer. 2015 Nov;25(9):1724-30. doi: 10.1097/IGC.0000000000000549.
6
Prevalence, patterns, and perceived value of complementary and alternative medicine among cancer patients: a cross-sectional, descriptive study.癌症患者中补充和替代医学的患病率、模式及感知价值:一项横断面描述性研究。
BMC Complement Altern Med. 2017 Jun 30;17(1):345. doi: 10.1186/s12906-017-1853-6.
7
Complementary/alternative medicine use in a comprehensive cancer center and the implications for oncology.综合癌症中心的补充/替代医学使用情况及其对肿瘤学的影响。
J Clin Oncol. 2000 Jul;18(13):2505-14. doi: 10.1200/JCO.2000.18.13.2505.
8
Prevalence and correlates of complementary and alternative medicine use among diabetic patients in Beirut, Lebanon: a cross-sectional study.黎巴嫩贝鲁特的糖尿病患者中补充和替代医学的使用情况及其相关性:一项横断面研究。
BMC Complement Altern Med. 2014 Jun 6;14:185. doi: 10.1186/1472-6882-14-185.
9
Characteristics of users and implications for the use of complementary and alternative medicine in Ghanaian cancer patients undergoing radiotherapy and chemotherapy: a cross- sectional study.加纳癌症放疗和化疗患者中补充和替代医学使用者的特征及其应用意义:一项横断面研究。
BMC Complement Altern Med. 2013 Jan 19;13:16. doi: 10.1186/1472-6882-13-16.
10
The experiences of persons living with HIV who participate in mind-body and energy therapies: a systematic review protocol of qualitative evidence.参与身心与能量疗法的艾滋病病毒感染者的经历:定性证据的系统评价方案
JBI Database System Rev Implement Rep. 2015 Oct;13(10):41-9. doi: 10.11124/jbisrir-2015-2321.

引用本文的文献

1
Bridging the gap: attitudes and practices toward complementary and alternative medicine among oncology patients and healthcare professionals in Croatia.缩小差距:克罗地亚肿瘤患者与医疗保健专业人员对补充和替代医学的态度与实践
Front Psychol. 2025 Jan 29;16:1531111. doi: 10.3389/fpsyg.2025.1531111. eCollection 2025.
2
Adherence to lifestyle recommendations among Norwegian cancer survivors and the impact of traditional and complementary medicine use: the Tromsø Study 2015-2016.挪威癌症幸存者对生活方式建议的遵从情况,以及传统和补充医学使用的影响:2015-2016 年特罗姆瑟研究。
BMC Complement Med Ther. 2023 Aug 19;23(1):292. doi: 10.1186/s12906-023-04123-4.
3
Use of traditional and complementary medicine among Norwegian cancer patients in the seventh survey of the Tromsø study.挪威癌症患者在特罗姆瑟研究第七次调查中使用传统和补充医学。
BMC Complement Altern Med. 2019 Nov 29;19(1):341. doi: 10.1186/s12906-019-2762-7.
4
Exploring the Use of Complementary and Alternative Medicine in Cancer Patients.探讨癌症患者对补充和替代医学的使用。
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419854134. doi: 10.1177/1534735419854134.
5
Exploring the Use of Complementary and Alternative Medicine in Cancer Patients.探索癌症患者对补充和替代医学的应用。
Integr Cancer Ther. 2019 Jan-Dec;18:1534735419846986. doi: 10.1177/1534735419846986.
6
Complementary and Alternative Medicines and Patients With Breast Cancer: A Case of Mortality and Systematic Review of Patterns of Use in Patients With Breast Cancer.补充与替代医学与乳腺癌患者:一例死亡病例及乳腺癌患者使用模式的系统评价
Plast Surg (Oakv). 2017 Nov;25(4):275-283. doi: 10.1177/2292550317716126. Epub 2017 Aug 22.
7
Mechanisms of Phytonutrient Modulation of Cyclooxygenase-2 (COX-2) and Inflammation Related to Cancer.植物营养素对环氧化酶-2(COX-2)的调节机制以及与癌症相关的炎症
Nutr Cancer. 2018 Apr;70(3):350-375. doi: 10.1080/01635581.2018.1446091. Epub 2018 Mar 26.
8
Use of Complementary and Alternative Medicine Among Newly Diagnosed Breast Cancer Patients in Malaysia: An Early Report From the MyBCC Study.马来西亚新诊断乳腺癌患者补充和替代医学的使用情况:MyBCC研究的早期报告
Integr Cancer Ther. 2018 Jun;17(2):312-321. doi: 10.1177/1534735417745248. Epub 2017 Dec 8.
9
Supporting Adolescents and Young Adults with Cancer: Oncology Provider Perceptions of Adolescent and Young Adult Unmet Needs.支持患癌青少年和青年:肿瘤学医护人员对青少年和青年未满足需求的看法。
J Adolesc Young Adult Oncol. 2017 Dec;6(4):519-523. doi: 10.1089/jayao.2017.0011. Epub 2017 Jun 12.
10
Complementary and Alternative Medicine Use at a Comprehensive Cancer Center.一家综合癌症中心的补充和替代医学应用
Integr Cancer Ther. 2017 Mar;16(1):104-109. doi: 10.1177/1534735416643384. Epub 2016 May 4.

本文引用的文献

1
Estrogenic botanical supplements, health-related quality of life, fatigue, and hormone-related symptoms in breast cancer survivors: a HEAL study report.植物雌激素补充剂、与健康相关的生活质量、疲劳和乳腺癌幸存者的激素相关症状:HEAL 研究报告。
BMC Complement Altern Med. 2011 Nov 8;11:109. doi: 10.1186/1472-6882-11-109.
2
Lymphedema after breast or gynecological cancer: use and effectiveness of mainstream and complementary therapies.乳腺癌或妇科癌症后的淋巴水肿:主流和补充疗法的使用和效果。
J Altern Complement Med. 2011 Sep;17(9):867-9. doi: 10.1089/acm.2010.0456.
3
Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths.癌症统计数据,2011 年:消除社会经济和种族差异对癌症过早死亡的影响。
CA Cancer J Clin. 2011 Jul-Aug;61(4):212-36. doi: 10.3322/caac.20121. Epub 2011 Jun 17.
4
Complementary and alternative medicine use in oncology: a questionnaire survey of patients and health care professionals.补充和替代医学在肿瘤学中的应用:患者和医疗保健专业人员的问卷调查。
BMC Cancer. 2011 May 24;11:196. doi: 10.1186/1471-2407-11-196.
5
Acupuncture for hot flashes in patients with prostate cancer.针灸治疗前列腺癌患者热潮红。
Urology. 2010 Nov;76(5):1182-8. doi: 10.1016/j.urology.2010.03.033. Epub 2010 May 21.
6
Patient-doctor communication: use of complementary and alternative medicine by adult patients with cancer.医患沟通:成年癌症患者对补充和替代医学的使用
J Soc Integr Oncol. 2010 Spring;8(2):56-64.
7
Complementary and alternative medicine use among adults and children: United States, 2007.2007年美国成人和儿童使用补充与替代医学的情况
Natl Health Stat Report. 2008 Dec 10(12):1-23.
8
A systematic review of the effectiveness of Chinese herbal medication in symptom management and improvement of quality of life in adult cancer patients.
Complement Ther Med. 2009 Apr;17(2):92-120. doi: 10.1016/j.ctim.2008.11.002. Epub 2008 Dec 25.
9
The effect of St. John's wort on the pharmacokinetics, metabolism and biliary excretion of finasteride and its metabolites in healthy men.
Eur J Pharm Sci. 2009 Mar 2;36(4-5):433-43. doi: 10.1016/j.ejps.2008.11.009. Epub 2008 Nov 27.
10
Acupuncture for the treatment of hot flashes in breast cancer patients, a randomized, controlled trial.针刺治疗乳腺癌患者潮热的随机对照试验。
Breast Cancer Res Treat. 2009 Jul;116(2):311-6. doi: 10.1007/s10549-008-0210-3. Epub 2008 Oct 7.

综合癌症中心患者诊断后开始采用补充和替代医学的流行情况及其相关因素。

Prevalence and correlates of postdiagnosis initiation of complementary and alternative medicine among patients at a comprehensive cancer center.

机构信息

Duke University Medical Center, Durham, NC 27705, USA.

出版信息

J Oncol Pract. 2013 Jan;9(1):34-41. doi: 10.1200/JOP.2012.000634.

DOI:10.1200/JOP.2012.000634
PMID:23633969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3545661/
Abstract

PURPOSE

Patients with cancer increasingly use complementary and alternative medicine (CAM) in conjunction with conventional oncology treatments. Previous studies have not investigated postdiagnosis initiation of CAM therapies or independent correlates of use of individual CAM modalities. The purpose of this study was to determine the prevalence and correlates of individual CAM modalities initiated after cancer diagnosis.

METHODS

A cross-sectional survey was conducted of a random sample of adults with a cancer diagnosis (N = 1,228) seeking care at a National Cancer Institute-designated comprehensive cancer center within a 12-month period.

RESULTS

The majority of patients were female (64.7%), white (86.9%), and married (72.8%).Three-quarters (75.2%) used at least one CAM modality, and 57.6% of those using CAM initiated use after cancer diagnosis. For all CAM therapies combined, women were 1.7 times more likely than men to initiate any CAM therapy after cancer diagnosis. However, when CAM modalities were differentiated by type, men and women were equally likely to initiate all therapies except for psychotherapy and mind-body approaches. Postdiagnosis initiation of every CAM modality, except mind-body therapies, differed by cancer type.

CONCLUSION

A significant proportion of patients initiated CAM use after diagnosis. However, specific type of CAM initiated varied by demographics and cancer type, suggesting there is not a "typology" of CAM user. Optimal comprehensive cancer treatment, palliation, and survivorship care will require patient and provider education regarding CAM use by modality type; improved provider-patient communication regarding potential benefits, limitations, and risks; and institutional policies to support integrated conventional and CAM treatment.

摘要

目的

癌症患者越来越多地将补充和替代医学(CAM)与传统肿瘤学治疗相结合。以前的研究没有调查过癌症诊断后 CAM 治疗的开始或单独使用 CAM 模式的相关因素。本研究的目的是确定癌症诊断后开始使用的各种 CAM 模式的流行率和相关因素。

方法

对在国家癌症研究所指定的综合癌症中心接受治疗的癌症患者(N=1228)进行了横断面调查,这些患者在 12 个月内随机抽样。

结果

大多数患者为女性(64.7%)、白人(86.9%)和已婚(72.8%)。四分之三(75.2%)的患者使用了至少一种 CAM 模式,其中 57.6%的 CAM 使用者在癌症诊断后开始使用。对于所有 CAM 疗法的组合,女性在癌症诊断后开始任何 CAM 疗法的可能性是男性的 1.7 倍。然而,当按类型区分 CAM 模式时,男性和女性开始所有疗法的可能性相同,除了心理疗法和身心方法。除身心疗法外,所有 CAM 模式的诊断后启动情况都因癌症类型而异。

结论

相当一部分患者在诊断后开始使用 CAM。然而,启动的特定类型的 CAM 因人口统计学和癌症类型而异,这表明不存在“CAM 用户类型学”。最佳的综合癌症治疗、缓解和生存护理将需要患者和提供者接受关于按模式类型使用 CAM 的教育;改善提供者-患者之间关于潜在益处、局限性和风险的沟通;以及制定支持常规和 CAM 治疗综合的机构政策。